These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 13213529)

  • 1. [Effects of a new antibiotic (puromycin) on sleeping disease (T. gambiense)].
    TRINCAO C; ALMEIDA FRANCO LD; NOGUEIRA A; PINTO AR; MUHLPFORDI H
    Med Contemp; 1954 Aug; 72(8):391-2. PubMed ID: 13213529
    [No Abstract]   [Full Text] [Related]  

  • 2. Puromycin in human sleeping sickness; a seventeen month follow-up.
    FRANCO A; MUHLPFORDT H; NOGUEIRA A; PINTO AR; TRINCAO C
    Antibiot Annu; 1955-1956; 3():596-9. PubMed ID: 13355333
    [No Abstract]   [Full Text] [Related]  

  • 3. Final report on the first use of puromycin for the treatment of sleeping sickness.
    FRANCO A; NOGUEIRA A; PINTO AR; TRINCAO C
    Am J Trop Med Hyg; 1956 Sep; 5(5):784-5. PubMed ID: 13362742
    [No Abstract]   [Full Text] [Related]  

  • 4. [Second report on the use of stylomycin in the treatment of human trypanosomiasis caused by Trypanosoma gambiense].
    HEULS J; ORIO J; CECCALDI J; MERVEILLE P
    Bull Soc Pathol Exot Filiales; 1958; 51(1):108-13. PubMed ID: 13536780
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of sleeping sickness with stylomycin; results two years later].
    FRANCO A; MUHLPFORDT H; NOGUEIRA AR; PINTO AR; TRINCAO C
    Rev Port Med Mil; 1956; 4(1):109-11. PubMed ID: 13390097
    [No Abstract]   [Full Text] [Related]  

  • 6. First report on the treatment of sleeping sickness with puromycin.
    TRINCAO C; FRANCO A; NOGUEIRA A; PINTO AR; MUHLPFORDT H
    Am J Trop Med Hyg; 1955 Jan; 4(1):13-7. PubMed ID: 13228843
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibility of Grammomys surdaster thicket rats to Trypanosoma brucei gambiense infection.
    Büscher P; Bin Shamamba SK; Ngoyi DM; Pyana P; Baelmans R; Magnus E; Van Overmeir C
    Trop Med Int Health; 2005 Sep; 10(9):850-5. PubMed ID: 16135191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of human African trypanosomiasis--very useful or too far removed?
    Kennedy PG
    Trans R Soc Trop Med Hyg; 2007 Nov; 101(11):1061-2. PubMed ID: 17548098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of Trypanosoma brucei gambiense group 1 in pigs from the Fontem sleeping sickness focus in Cameroon.
    Simo G; Asonganyi T; Nkinin SW; Njiokou F; Herder S
    Vet Parasitol; 2006 Jun; 139(1-3):57-66. PubMed ID: 16567049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pentylthiarsaphenylmelamine (Mel W) in the treatment of trypanosomiasis due to T. gambiense].
    de JONGH R; FRIEDHEIM EA
    Bull Soc Pathol Exot Filiales; 1959; 52():769-78. PubMed ID: 14407809
    [No Abstract]   [Full Text] [Related]  

  • 11. [Double trypanosomal chancre revealing West African trypanosomiasis in a Frenchman living in Gabon].
    Hope-Rapp E; Moussa Coulibaly O; Klement E; Danis M; Bricaire F; Caumes E
    Ann Dermatol Venereol; 2009 Apr; 136(4):341-5. PubMed ID: 19361701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma brucei gambiense: study of population genetic structure of Central African stocks using amplified fragment length polymorphism (AFLP).
    Simo G; Cuny G; Demonchy R; Herder S
    Exp Parasitol; 2008 Feb; 118(2):172-80. PubMed ID: 17850792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Practical value of the complement fixation reaction in trypanosomiasis gambiense. II. Complement fixation reaction in a case of relapse after medicinal treatment].
    EVENS F; SCHOENAERS F; NEUJEAN G; KAECKENBEEK A; STYNS J
    Ann Soc Belg Med Trop (1920); 1953 Oct; 33(5):389-402. PubMed ID: 13139073
    [No Abstract]   [Full Text] [Related]  

  • 14. Contributions of experimental mouse models to the understanding of African trypanosomiasis.
    Antoine-Moussiaux N; Magez S; Desmecht D
    Trends Parasitol; 2008 Sep; 24(9):411-8. PubMed ID: 18684669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanosoma brucei gambiense in domestic livestock of Kogo and Mbini foci (Equatorial Guinea).
    Cordon-Obras C; Berzosa P; Ndong-Mabale N; Bobuakasi L; Buatiche JN; Ndongo-Asumu P; Benito A; Cano J
    Trop Med Int Health; 2009 May; 14(5):535-41. PubMed ID: 19320872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild fauna as a probable animal reservoir for Trypanosoma brucei gambiense in Cameroon.
    Njiokou F; Laveissière C; Simo G; Nkinin S; Grébaut P; Cuny G; Herder S
    Infect Genet Evol; 2006 Mar; 6(2):147-53. PubMed ID: 16236560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human African trypanosomiasis: clinical presentation and immune response.
    Sternberg JM
    Parasite Immunol; 2004; 26(11-12):469-76. PubMed ID: 15771682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and neuropathogenesis issues in human African trypanosomiasis.
    Kennedy PG
    Int J Parasitol; 2006 May; 36(5):505-12. PubMed ID: 16546191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vervet monkey (Chlorocebus aethiops) as an experimental model for Trypanosoma brucei gambiense human African trypanosomiasis: a clinical, biological and pathological study.
    Ouwe-Missi-Oukem-Boyer O; Mezui-Me-Ndong J; Boda C; Lamine I; Labrousse F; Bisser S; Bouteille B
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):427-36. PubMed ID: 16325877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.